TheProfitWatch

ANEB - Anebulo Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.56 0.19 (7.42%) --- --- --- --- 0.16 (6.25%) 0.05 (1.85%) 0.05 (1.85%)

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.04
Diluted EPS:
-0.04
Basic P/E:
-68.75
Diluted P/E:
-68.75
RSI(14) 1m:
100.0
VWAP:
2.71
RVol:

Events

Period Kind Movement Occurred At
1m Price increase 1m 2.75 +0.05 (+1.85%) Oct 15 16:37

Related News